Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Quick Stats
Jun 03, 202655.2
AI Score
HOLD1.01
Volume Ratio
May 07, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
AMLX Stock Summary
Last updated Jun 03, 2026
AMLX is currently trading at $13.2, positioned below its 200-day moving average of $13.76, suggesting bearish momentum. The stock has a 52-week range of $4.76 to $18.605.
Technical Analysis: The 50-day moving average stands at $15.22, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.484, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.063, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates AMLX at 55.2/100 with a HOLD recommendation.
AMLX (Amylyx Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Jun 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.484 |
| CMF (20) | -0.063 |
| ROC (10) | 3.846 |
| ADX (14) | 22.419 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.527 |
| AROONOSC (14) | -28.571 |
| WILLAMS %R (14) | -65.198 |
| MFI (14) | 43.439 |
AMLX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
AMLX Price vs Max Options Open Interest
AMLX Max Change In Options Open Interest
AMLX Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AMLX Daily Out of Money Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AMLX Daily In the Money Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AMLX Most Active Options by Volume(near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Amylyx Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
AMLX Moving Averages Analysis
AMLX (Amylyx Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 03, 2026
| Days | MA |
|---|---|
| 10 | 13.8 |
| 20 | 14.03 |
| 30 | 14.87 |
| 50 | 15.22 |
| 100 | 14.8 |
| 200 | 13.76 |
AMLX Fundamental Analysis
| P/E (Forward) | 2.7739 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.5 billion |
| Earnings/Share ($) | -1.48 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.3847 |
| EPS Estimate Next Year ($) | -1.266 |
| WallStreet Target Price ($) | 23.4 |
| Most Recent Quarter |